{"id":213104,"date":"2026-07-10T18:24:13","date_gmt":"2026-07-10T18:24:13","guid":{"rendered":"https:\/\/www.europesays.com\/ch-fr\/213104\/"},"modified":"2026-07-10T18:24:13","modified_gmt":"2026-07-10T18:24:13","slug":"la-sante-renforce-son-emprise-sur-lindice-vedette-de-la-bourse-suisse","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch-fr\/213104\/","title":{"rendered":"La sant\u00e9 renforce son emprise sur l\u2019indice vedette de la bourse suisse"},"content":{"rendered":"<p>Le sp\u00e9cialiste des g\u00e9n\u00e9riques et biosimilaires Sandoz et le producteur de traitements dermatologiques Galderma rejoindront \u00e0 la rentr\u00e9e l\u2019indice vedette de la place financi\u00e8re suisse, le Swiss Market Index (SMI). Compos\u00e9 des 20 capitalisations les plus importantes, il comptera \u00e0 partir du 21\u00a0septembre six soci\u00e9t\u00e9s des sciences de la vie \u2013 Roche, Novartis, Alcon et Lonza y figurant d\u00e9j\u00e0.<\/p>\n<p>L\u2019importance de ce secteur est d\u00e9j\u00e0 un des \u00e9l\u00e9ments distinctifs du SMI \u2013 en raison du poids de Roche et Novartis \u2013 mais le nouvel ajustement refl\u00e8te la diversit\u00e9 de la branche contribuant \u00e0 plus de 40% des exportations du pays. \u00abDepuis pr\u00e8s de vingt\u00a0ans, la cr\u00e9ation de valeur ne provient plus uniquement de la pharmacie traditionnelle, mais de l\u2019ensemble de l\u2019\u00e9cosyst\u00e8me de la sant\u00e9, qui englobe d\u00e9sormais les biotechnologies, les traitements sp\u00e9cialis\u00e9s et les dispositifs m\u00e9dicaux\u00bb, rappelle John Plassard, le responsable des investissements de la banque genevoise Cit\u00e9 Gestion.<\/p>\n","protected":false},"excerpt":{"rendered":"Le sp\u00e9cialiste des g\u00e9n\u00e9riques et biosimilaires Sandoz et le producteur de traitements dermatologiques Galderma rejoindront \u00e0 la rentr\u00e9e&hellip;\n","protected":false},"author":2,"featured_media":213105,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[6],"tags":[45,44,1226,43,828,967,174,23,10873],"class_list":["post-213104","post","type-post","status-publish","format-standard","has-post-thumbnail","category-economie","tag-business","tag-economie","tag-economie-suisse","tag-economy","tag-entreprises","tag-finance","tag-premium","tag-suisse","tag-swisscom"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch_fr\/116897085251239285","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/posts\/213104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/comments?post=213104"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/posts\/213104\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/media\/213105"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/media?parent=213104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/categories?post=213104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/tags?post=213104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}